Editor's Choice – ECAR (Endovasculaire ou Chirurgie dans les Anévrysmes aorto-iliaques Rompus): A French Randomized Controlled Trial of Endovascular Versus Open Surgical Repair of Ruptured Aorto-iliac Aneurysms

Pascal Desgranges(Centre Hospitalier Universitaire Henri-Mondor), Hicham Kobeiter(Centre Hospitalier Universitaire Henri-Mondor), Sandrine Katsahian(Centre Hospitalier Universitaire Henri-Mondor), M. Bouffi(Hôpital Nord), Pierre Gouny(Centre Hospitalier Régional Universitaire de Brest), J P Favre(Centre Hospitalier Universitaire de Saint-Étienne), Jean-Marc Alsac(Hôpital Européen Georges-Pompidou), Jonathan Sobocinski, Pierre Julia(Hôpital Européen Georges-Pompidou), Yves Alimi(Hôpital Nord), Éric Steinmetz, Stéphan Haulon, Pierre Alric(Centre Hospitalier Universitaire de Montpellier), Ludovic Canaud(Centre Hospitalier Universitaire de Montpellier), Yves Castier(Hôpital Bichat-Claude-Bernard), Elixène Jean‐Baptiste(Centre Hospitalier Universitaire de Nice), Réda Hassen‐Khodja(Centre Hospitalier Universitaire de Nice), Patrick Lermusiaux, Patrick Feugier, Laurence Destrieux‐Garnier(Centre Hospitalier Annecy Genevois), Anaïs Charles‐Nelson(Centre Hospitalier Universitaire Henri-Mondor), J. Marzelle(Centre Hospitalier Universitaire Henri-Mondor), Michał Majewski(Centre Hospitalier Universitaire Henri-Mondor), A. Bourmaud(Institute Cancer De La Loire Lucien Neuwirth), J P Becquemin(Centre Hospitalier Universitaire Henri-Mondor)
European Journal of Vascular and Endovascular Surgery
May 20, 2015
Cited by 183Open Access
Full Text

Abstract

OBJECTIVES/BACKGROUND: ECAR (Endovasculaire ou Chirurgie dans les Anévrysmes aorto-iliaques Rompus) is a prospective multicentre randomized controlled trial including consecutive patients with ruptured aorto-iliac aneurysms (rAIA) eligible for treatment by either endovascular (EVAR) or open surgical repair (OSR). Inclusion criteria were hemodynamic stability and computed tomography scan demonstrating aorto-iliac rupture. METHODS: Randomization was done by week, synchronously in all centers. The primary end point was 30 day mortality. Secondary end points were post-operative morbidity, length of stay in the intensive care unit (ICU), amount of blood transfused (units) and 6 month mortality. RESULTS: From January 2008 to January 2013, 107 patients (97 men, 10 women; median age 74.4 years) were enrolled in 14 centers: 56 (52.3%) in the EVAR group and 51 (47.7%) in the OSR group. The groups were similar in terms of age, sex, consciousness, systolic blood pressure, Hardman index, IGSII score, type of rupture, use of endoclamping balloon, and levels of troponin, creatinine, and hemoglobin. Delay to treatment was higher in the EVAR group (2.9 vs. 1.3 hours; p < .005). Mortality at 30 days and 1 year were not different between the groups (18% in the EVAR group vs. 24% in the OSR group at 30 days, and 30% vs. 35%, respectively, at 1 year). Total respiratory support time was lower in the EVAR group than in the OSR group (59.3 hours vs. 180.3 hours; p = .007), as were pulmonary complications (15.4% vs. 41.5%, respectively; p = .050), total blood transfusion (6.8 vs. 10.9, respectively; p = .020), and duration of ICU stay (7 days vs. 11.9 days, respectively; p = .010). CONCLUSION: In this study, EVAR was found to be equal to OSR in terms of 30 day and 1 year mortality. However, EVAR was associated with less severe complications and less consumption of hospital resources than OSR.


Related Papers

No related papers found

Powered by citation graph analysis